amodiaquine and cgp-56697

amodiaquine has been researched along with cgp-56697 in 121 studies

Research

Studies (121)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	16 (13.22)	29.6817
2010's	71 (58.68)	24.3611
2020's	34 (28.10)	2.80

Authors

Authors	Studies
D'Alessandro, U; Fanello, CI; Karema, C; Ngamije, D; van Doren, W; Van Overmeir, C	1
Adedeji, AA; Amoo, AO; Fateye, BA; Gbotosho, GO; Happi, CT; Sowunmi, A; Tambo, E	1
Kim, M; Mutabingwa, TK; Whitty, CJ; Wiseman, V	1
Morrow, RH	1
Dokomajilar, C; Dorsey, G; Guiguemde, RT; Ouedraogo, JB; Rosenthal, PJ; Rouamba, N; Tinto, H; Zongo, I	1
Clark, TD; Dokomajilar, C; Dorsey, G; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, S	1
Adedeji, AA; Fateye, BA; Fehintola, FA; Folarin, OA; Gbotosho, GO; Happi, CT; Sowunmi, A; Tambo, E	1
Dokomajilar, C; Dorsey, G; Ouédraogo, JB; Rosenthal, PJ; Rouamba, N; Séré, Y; Zongo, I	1
Agyei-Baffour, P; Ajayi, IO; Balyeku, A; Bateganya, F; Browne, EN; Cousens, S; Doamekpor, L; Garshong, B; Munguti, K; Pagnoni, F; Yusuf, B	1
Bienzle, U; Dippmann, AK; Harms, G; Mockenhaupt, FP	1
Clark, TD; Dorsey, G; Jagannathan, P; Kamya, MR; Maiteki-Sebuguzi, C; Njama-Meya, D; Nzarubara, B; Rosenthal, PJ; Staedke, SG; Talisuna, AO; Yau, VM	1
Adjei, GO; Alifrangis, M; Badoe, EV; Goka, BQ; Hoegberg, LC; Kitcher, ED; Kurtzhals, JA; Lamptey, R; Rodrigues, OP	1
Ajayi, IO; Bateganya, F; Boateng, S; Browne, EN; Cousens, S; Falade, CO; Gbotosho, GO; Happi, C; Mugittu, K; Nanyunja, M; Pagnoni, F; Yar, D; Yusuf, B	1
Adjei, S; Amemasor, S; Ansong, D; Bührlen, M; Heidemann, H; Hogan, B; Klein, P; Kobbe, R; Kreuels, B; Loag, W; May, J; Nielsen, MV; Thompson, WN; Vohwinkel, J	1
Boly, MD; Deloron, P; Faucher, JF; Houzé, S; Le Bras, J	1
Joloba, M; Kiggundu, M; Nawaz, F; Nsobya, SL; Rosenthal, PJ	1
Oguonu, T; Okafor, HU; Shu, EN	1
Djoman, K; Faye, B; Gaye, O; Ndiaye, JL; Ndiaye, PS; Offianan, AT; Penali, L; Sylla, K; Tine, RC; Touré, W	1
Bousema, T; Drakeley, C; Ghani, AC; Griffin, JT; Okell, L; Omar, S; Sauerwein, R; Sawa, P; Shekalaghe, S; Sutherland, C	1
Fatunmbi, B; Folarin, O; Gbotosho, GO; Happi, CT; Michael, O; Okuboyejo, T; Sowunmi, A	1
Folarin, OA; Gbotosho, GO; Happi, CT; Michael, OS; Oduola, AM; Okuboyejo, T; Sowunmi, A	1
Adewoye, EO; Folarin, OO; Gbotosho, GO; Happi, CT; Okuboyejo, TM; Sowunmi, A	1
Adewoye, EO; Folarin, OA; Gbotosho, GO; Happi, CT; Michael, OS; Okuboyejo, TM; Sowunmi, A	1
Gbotosho, GO; Happi, CT; Okuboyejo, TM; Sowunmi, A	2
Barry, A; Cissé, B; Faye, B; Gaye, O; Gueye, A; Lameyre, V; Ndiaye, D; Ndiaye, I; Ndiaye, JL; Tchania, C; Tine, R	1
Baliraine, FN; Rosenthal, PJ	1
Bassene, C; Bygbjerg, IC; Faye, B; Gaye, O; Magnussen, P; Ndiaye, JL; Ndiaye, M; Ndour, CT; Ndour, JD; Sylla, K; Tine, RC	1
Atua, B; Dhorda, M; Espié, E; Flévaud, L; Guerin, PJ; Lima, A; Palma Urrutia, PP; Sompwe, EM	1
Dembele, D; Dicko, A; Djimde, AA; Doumbo, OK; Fofana, B; Gaudart, J; Giorgi, R; Sagara, I; Sanogo, K; Sidibe, B; Togo, A; Toure, S	1
D'Alessandro, U; Donegan, S; Tudur Smith, C; Williamson, P	1
Baird, JK; de Monbrison, F; Laihad, F; Picot, S; Ruckert, P; Suprianto, S; Sutanto, I; von Bethmann, A; Widiaty, A	1
Agbo, YM; Barrette, A; Bogreau, H; Dorkenoo, MA; Kutoati, S; Morgah, K; Sodahlon, YK	1
Adjei, GO; Alifrangis, M; Goka, BQ; Hoegberg, LC; Kurtzhals, JA; Oduro-Boatey, C; Rodrigues, OP	1
El Menan, H; Faye, B; Faye, O; Gaye, O; Kakpo, CA; Kiki-Barro, CP; Kuété, T; Moussa, K; Ndiaye, JL; Nkoa, T; Same-Ekobo, A; Sylla, K; Tine, RC	1
Dworkin, J; Gardner, A; Janvier, M; Treaba, D	1
Ashley, EA; Baudin, E; Branger, M; Bruneel, A; Carn, G; Comte, E; Guérin, PJ; Jones, JJ; Jullien, V; Kiechel, JR; Mazinda, CS; Pinoges, L; Schramm, B; Smith, R; Sundaygar, T; Valeh, P; Zolia, YM	1
Ashley, EA; Baudin, E; Boum, Y; Carn, G; Comte, E; Dhorda, M; Guérin, PJ; Houzé, P; Jones, JJ; Jullien, V; Kiechel, JR; Mazinda, CS; Pinoges, L; Schramm, B; Smith, R; Sundaygar, T; Valeh, P; Zolia, YM	1
D'Alessandro, U; Grobusch, MP; Lutumba, P; Muhindo Mavoko, H; Nabasumba, C; Tinto, H; Van Geertruyden, JP	1
Abiodun, OO; Lawal, OA; Ojurongbe, O; Okeniyi, JA; Oyelami, OA; Oyeniyi, AJ	1
Djallé, D; Laganier, R; Le Faou, A; Manirakiza, A; Njuimo, SP; Rogier, C	1
D'Alessandro, U; Diallo, S; Guiguemdé, TR; Guiraud, I; Kazienga, A; Kpoda, H; Ouédraogo, JB; Sorgho, H; Tinto, H; Valea, I; Zongo, I	1
Cheah, PY; Day, NP; Dondorp, AM; Fanello, CI; Nosten, F; Onyamboko, MA; Tarning, J; Tshefu, KA; White, NJ; Wongsaen, K	1
Alonso, P; Bassat, Q; Carvalho, E; Enosse, S; Guinovart, C; Macete, E; Matsinhe, G; Mussa, A; Mutemba, R; Naueia, E; Nhacolo, A; Nhama, A; Sanz, S; Sevene, E; Tiago, A; Warsame, M	1
Agomo, C; Agomo, P; Aina, O; Banjo, O; Meremikwu, M; Ntadom, G; Odey, F; Ogala, W; Oguche, S; Ogunrinde, G; Okafor, HU; Okuboyejo, T; Sofola, T; Sowunmi, A; Watila, I	1
Adji, GE; Ako, AB; Assi, SB; Bassinka, I; Beourou, S; Brou, MJ; Coulibaly, B; Coulibaly, MA; Ehouman, MF; Gnamien, LA; Kadjo, F; N'Guessan, TL; Soumahoro, A; Tano, MA; Toure, OA	1
Claeys, Y; D'Alessandro, U; De Crop, M; Halidou, T; Kalanda, G; Menten, J; Mulenga, M; Mutabingwa, T; Mwakazanga, D; Mwapasa, V; Nambozi, M; Phiri, LK; Ravinetto, R; Schurmans, C; Tagbor, H; Thriemer, K; Traore, M; Valea, I; Van Geertruyden, JP	1
Ali, IM; Chedjou, JP; Ekollo, AM; Evehe, MS; Froeschl, G; Heumann, C; Mansmann, U; Mbacham, WF; Moyeh, MN; Ndikum, VN; Ngongang, EO; Nji, AM; Ogundahunsi, O	1
Arif, SM; Faiz, MA; Hafiz, SA; Hossain, MM; Hussain, MA; Islam, MN; Rahman, MR; Samad, R; Yunus, EB	1
Aboderin, O; Badejoko, O; Fatusi, A; Loto, O; Ogunniyi, S; Ukah, M	1
Derra, K; Diallo-Nakanabo, S; Guiguemde, TR; Kazienga, A; Ouedraogo, JB; Owusu-Dabo, E; Sondo, P; Sorgho, H; Tarnagda, Z; Tinto, H; Valea, I; Zampa, O	1
Aderoyeje, T; Adewoye, EO; Akano, K; Ayede, AI; Fatunmbi, B; Ntadom, G; Sowunmi, A	2
Basco, LK; Bitemo, M; Casimiro, PN; Diassivy Matondo, B; Koukouikila-Koussounda, F; Ndounga Diakou, LA; Ndounga, M; Ntoumi, F	1
Baird, JK; Boni, MF; Dondorp, AM; Farrar, J; Lam, HM; Nguyen, TD; Olliaro, P; Thwaites, GE; White, NJ	1
Belay, K; Chang, MA; Conrad, MD; Dorsey, G; Kamya, MR; Kapella, BK; Katureebe, C; Kigozi, R; Lugemwa, M; Okui, P; Rosenthal, PJ; Staedke, SG; Yeka, A	1
Azman, AS; Azuma, P; Bocquin, A; Cabrol, JC; Cannas, A; Ciglenecki, I; de Smet, M; Gignoux, E; Job, D; Kurth, A; Logue, C; Massaquoi, M; Petrucci, R; Potet, J; Pottage, T; Serafini, M; Sterk, E; Strecker, T; Suzuki, M; Tiffany, A; Yue, C	1
Abokyi, LN; Afari-Asiedu, S; Asante, KP; Febir, LG; Gyapong, M; Kwarteng, A; Ogutu, B; Owusu-Agyei, S	1
Batson, JS; Bempong, DK; Lukulay, PH; Ranieri, N; Satzger, RD; Verbois, L	1
Ampromfi, AA; Antwi, G; Claeys, Y; D'Alessandro, U; De Crop, M; Gbekor, P; Hachizovu, S; Kabuya, JB; Kalanda, G; Kalilani-Phiri, L; Madanitsa, M; Menten, J; Mulenga, J; Mulenga, M; Mutabingwa, T; Mwapasa, V; Nambozi, M; Pekyi, D; Ravinetto, R; Schurmans, C; Tagbor, H; Tahita, MC; Thriemer, K; Tinto, H; Traoré-Coulibaly, M; Valéa, I; Van Geertruyden, JP; Van Overmeir, C	1
Derra, K; Diallo Nakanabo, S; Guiguemdé, TR; Kazienga, A; Ouédraogo, JB; Owusu-Dabo, E; Sondo, P; Sorgho, H; Tarnagda, Z; Tinto, H; Valéa, I; Zampa, O	1
Ali, D; Gutman, J; Luka, M; Makuta, G; Marthey, D; Mathanga, DP; Mwandama, D; Paczkowski, M; Sande, J; Troell, P	1
Adjeloh, P; Agbeko, F; Agbo, YM; Awokou, F; Dorkenoo, AM; Layibo, Y; Ringwald, P; Sossou, E; Yakpa, K; Yehadji, D	1
Ashley, EA; Guérin, PJ; Houzé, P; Houzé, S; Jones, JJ; Jullien, V; Kiechel, JR; Le Bras, J; Maïga-Ascofaré, O; Otienoburu, SD; Schramm, B; Zolia, YM	1
Bahizi Bizoza, P; Bart, A; Bil, K; Bousema, T; de Wit, M; Funk, AL; Moussally, K; Nkuba, DA; Piriou, E; Siddiqui, R	1
Baraka, V; D'Alessandro, U; da Luz, RI; Kambugu, A; Lutumba, P; Mavoko, HM; Nabasumba, C; Rosanas-Urgell, A; Tinto, H; Van Geertruyden, JP	1
Afonso, M; Dimbu, PR; Ferreira, CM; Fortes, F; Garrett, DO; Halsey, ES; He, Y; Kelley, JS; Kiniffo, R; Macaia, AP; Mbounga, E; Patel, DS; Plucinski, MM; Quivinja, J; Ringwald, P; Samutondo, C; Talundzic, E; Udhayakumar, V	1
Aderoyeje, T; Adewoye, EO; Agomo, C; Agomo, P; Akano, K; Ayede, AI; Fatunmbi, B; Folarin, OA; Gbotosho, GO; Happi, CT; Ibironke, FO; Meremikwu, M; Ntadom, G; Ogala, W; Oguche, S; Okafor, HU; Sowunmi, A; Watila, I	1
Aderoyeje, T; Adowoye, E; Agomo, C; Agomo, P; Akano, K; Ayede, A; Fatunmbi, B; Folarin, O; Gbotosho, G; Happi, C; Meremikwu, M; Ntadom, G; Ogala, W; Oguche, S; Okafor, H; Sowunmi, A; Watila, I	1
Aprioku, JS; Mankwe, AC	1
Andrade, BN; Davlantes, E; Dimbu, PR; Dos Santos Souza, S; Félix, J; Ferreira, CM; Florinda Joao, M; Fortes, F; Halsey, ES; Martins, JF; Mbounga, E; Owens, C; Plucinski, MM; Pode, D; Sanhangala, E; Talundzic, E; Udhayakumar, V; Wiesner, L	1
Banek, K; Chandramohan, D; Smith, SJ; Staedke, SG; Webb, EL	1
Abdulkadir, M; Aderoyeje, T; Agomo, C; Akano, K; Ambe, J; Ebenebe, JC; Emechebe, G; Ezeigwe, NM; Finomo, F; Folarin, OA; Happi, C; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Oyibo, W; Sowunmi, A; Useh, F; Wammanda, R	1
Chacky, F; Ishengoma, DS; Kabanywanyi, AM; Kakolwa, MA; Kamugisha, E; Kataraihya, JB; Lemnge, MM; Mahende, MK; Mandara, CI; Mandike, R; Menard, D; Mkude, S; Ngasala, B; Njau, R; Premji, Z; Warsame, M	1
Basco, LK; Chiabi, A; Whegang Youdom, S	1
Bah, I; Camara, A; Diakité, PS; Guilavogui, T; Kaba, I; Kourouma, D; Moriarty, LF; Plucinski, M; Sidibé, S; Zoumanigui, JS; Zoumanigui, K	1
Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P	1
Banda, CG; Barnes, KI; Maartens, G	1
Amara, A; Khoo, S; Lamorde, M; Waitt, C; Walimbwa, S	1
Abuaku, B; Duah-Quashie, NO; Gyasi, A; Koram, K; Malm, K; Matrevi, SA; Owusu-Antwi, F; Quashie, N; Quaye, L	1
Aderoyeje, T; Adewoye, EO; Agomo, C; Agomo, P; Akano, K; Akpoborie, O; Alebiosu, OT; Ambe, J; Amoo, S; Ayede, AI; Basorun, OK; Dokunmu, TM; Ebenebe, JC; Emechebe, G; Ezeigwe, NM; Fatunmbi, B; Finomo, F; Folarin, OA; Gbotosho, GO; Happi, C; Ibironke, FO; Jiya, N; Meremikwu, M; Mokuolu, O; Ntadom, G; Oduola, A; Ogala, W; Oguche, S; Okafor, C; Okafor, HU; Oyibo, W; Sowunmi, A; Useh, F; Wammanda, R; Watila, I; Wewe, OA	1
Bouyou-Akotet, MK; Fandeur, T; Koumba Lengongo, JV; Lekana-Douki, JB; M'Bondoukwé, NP; Mawili-Mboumba, DP; Moutombi Ditombi, B; Ndong Ngomo, JM; Offouga, CL; Ondzagha Megnie, GJ; Ringwald, P	1
Aderoyeje, T; Agomo, C; Akano, K; Akpoborie, O; Alebiosu, OT; Ambe, J; Ayede, AI; Bakre, A; Ebenebe, JC; Emechebe, G; Fatunmbi, B; Finomo, F; Folarin, OA; Gbotosho, GO; Happi, C; Jiya, N; Mokuolu, O; Ntadom, G; Oguche, S; Okafor, C; Sowunmi, A; Wammanda, R	1
Fungula, B; Inocencio da Luz, R; Kalabuanga, M; Lula Ntamba, Y; Lutumba, P; Muhindo Mavoko, H; Ntamabyaliro Nsengi, PM; Tona Lutete, G; Van Geertruyden, JP	1
Adegbite, BR; Adegnika, AA; Agnandji, ST; Dejon-Agobe, JC; Edoa, JR; Honkpehedji, YJ; Koehne, E; Kreidenweiss, A; Kremsner, PG; Kun, J; Lalremruata, A; Lell, B; Lotola-Mougueni, F; Mbong-Ngwese, M; Mombo-Ngoma, G; Mordmüller, B; Nguyen, TT; Obone Atome, FA; Ramharter, M; Safiou, AR; Velavan, TP; Zinsou, FJ	1
Bonkian, LN; d'Alessandro, U; Kazienga, A; Lingani, M; Mens, PF; Ouédraogo, JB; Ravinetto, R; Schallig, HDFH; Sorgho, H; Tinto, H; Valéa, I; Yerbanga, I	1
Bassat, Q; Baudin, E; Bretscher, MT; D'Alessandro, U; Dahal, P; Djimde, AA; Dorsey, G; Espié, E; Fofana, B; Ghani, AC; González, R; Griffin, J; Guerin, PJ; Juma, E; Karema, C; Lasry, E; Lell, B; Lima, N; Menéndez, C; Mombo-Ngoma, G; Moreira, C; Nikiema, F; Okell, LC; Ouédraogo, JB; Staedke, SG; Stepniewska, K; Tinto, H; Valea, I; Yeka, A	1
Amaratunga, C; Amato, R; Anvikar, AR; Ashley, E; Baidya, S; Behera, PK; Callery, JJ; Chau, NH; Cheah, PY; Chotivanich, K; Chutasmit, K; Day, NPJ; Dhorda, M; Dondorp, AM; Fairhurst, RM; Faiz, A; Fanello, C; Gantait, K; Ghosh, T; Gonçalves, S; Grobusch, MP; Hanboonkunupakarn, B; Heaton, J; Hien, TT; Hlaing, TM; Hoa, NT; Hoglund, RM; Huy, R; Imwong, M; Jacob, CG; Jittamala, P; Kaewmok, W; Kwiatkowski, DP; Lek, D; Lin, K; Mao, S; Maude, RJ; Mayxay, M; Miotto, O; Mohanty, AK; Mukaka, M; Newton, PN; Onyamboko, M; Oun, S; Pearson, RD; Peto, TJ; Pukrittayakamee, S; Pyae Phyo, A; Runcharern, R; Saelow, C; Satpathi, P; Satpathi, S; Smithuis, F; Sovann, Y; Sreng, S; Suon, S; Tarning, J; Thanh, NV; Thant, M; Thuy-Nhien, NT; Tripura, A; Tripura, R; Ul Islam, A; Valecha, N; van der Pluijm, RW; van Vugt, M; von Seidlein, L; Waithira, N; White, NJ; Winterberg, M; Woodrow, CJ; Yen, S	1
Badiane, AS; Dème, AB; Diallo, I; Diallo, MA; Dieye, B; Diongue, K; Gomis, JF; Ndiaye, D; Ndiaye, M; Ndiaye, YD; Seck, MC; Sow, D; Sy, M; Sy, SA; Yade, MS	1
Barry, N; Compaoré, YD; Kaboré, N; Nikiéma, F; Ouédraogo, JB; Somé, FA; Zongo, I; Zongo, M	1
Beavogui, AH; Bouedouno, P; Camara, A; Delamou, A; Diallo, MS; Dos Santos Souza, S; Doumbouya, A; Fofana, A; Guilavogui, T; Kelley, J; Kourouma, K; Plucinski, MM; Talundzic, E	1
Andreani, J; Boxberger, M; Delandre, O; Duflot, I; Fonta, I; Gendrot, M; Hutter, S; Jardot, P; La Scola, B; Le Bideau, M; Mosnier, J; Pradines, B; Rolland, C	1
Adehossi, E; Boureima, S; Hadiza, J; Hamidou, HH; Harouna, HK; Ibrahima, I; Laminou, IM; Mahamadou, A; Maman, D; Tidjani, IA; Yacouba, I	1
Blanshard, A; Hine, P	1
Denti, P; Kawuma, AN; Khoo, S; Lamorde, M; Pillai, GC; Walimbwa, SI; Wasmann, RE	1
Baguiya, A; Barry, N; Dianda, F; Héma, A; Hien, D; Kaboré, JMT; Kiba Koumaré, A; Kouanda, S; Nombré, Y; Savadogo, Y; Siribie, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB	1
Boreux, R; De Mol, P; Hayette, MP; Kabututu, PZ; Kayiba, NK; Mvumbi, DM; Mvumbi, GL; Situakibanza, HNT; Speybroeck, N; Umesumbu, SE; Yobi, DM	1
Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E	1
Abba, T; Angora, EK; Assi, SB; Bedia, VA; Daho, AK; Emmanuel, B; Kiki-Barro, PMC; Konate, AA; Menan, H; Tiacoh, LN; Toure, OA; Yavo, W	1
Diallo, M; Diarra, Y; Doumbia, L; Eckert, E; Haidara, DBB; Halsey, ES; Koita, OA; Koné, O; Krogstad, DJ; Lim, P; Ljolje, D; Lucchi, NW; Maiga, A; Mihigo, J; Moriarty, LF; Nace, D; Sangaré, L; Sango, HA; Sidibé, H; Talundzic, E; Udhayakumar, V; Woodfill, CJ	1
Berzosa, P; Edú Maye, CE; Garcia, L; Lao Seoane, AK; Legrand, E; Mbá Andeme, R; Menard, D; Ncogo, PR; Nsue Esidang, S; Ntabangana, SC; Oki Eburi, C; Phiri, WP; Riloha Rivas, M; Ringwald, P; Warsame, M	1
Chowell-Puente, G; Halsey, ES; Jones, S; Kahunu, GM; Kaputu, AK; Likwela, JL; Lucchi, N; Mavoko, HM; Moriarty, LF; Mulopo, PM; Muyembe Tamfum, JJ; Ngoyi, DM; Niang, M; Nkoli, PM; Ntamabyaliro, NY; Plucinski, MM; Rika, JM; Sadou, A; Schmedes, SE; Sompwe, EM; Subramaniam, G; Svigel, SS	1
Aide, P; Bassat, Q; Candrinho, B; Carvalho, E; Chidimatembue, A; Enosse, S; Halsey, ES; Lucchi, N; Macete, E; Mayor, A; Moriarty, LF; Nhacolo, A; Nhama, A; Nhamússua, L; Saifodine, A; Salvador, C; Svigel, SS; Zulliger, R	1
Dentinger, CM; Halsey, ES; Kapesa, L; Lucchi, NW; Moriarty, LF; Rakotoarisoa, A; Rakotomanga, TA; Rakotondrandriana, A; Rason, MA; Ratsimbasoa, CA; Razafindrakoto, J; Steinhardt, LC; Svigel, SS; Udhayakumar, V	1
Abuaku, B; Afriyie, PO; Bart-Plange, C; Duah-Quashie, NO; Ghansah, A; Gyasi, A; Koram, KA; Malm, KL; Owusu-Antwi, F; Quashie, N	1
Aboh, PM; Adzemye, LM; Akam, LF; Ali, IM; Alifrangis, M; Ambani, MCE; Ango, Z; Bigoga, JD; Chedjou, JPK; Dinza, G; Dongmo, CH; Douanla, A; Ewane, MS; Fomboh, CT; Fosah, DA; Kotcholi, GB; Ludovic, AJ; Mbacham, WF; Moyeh, MN; Nana, WD; Ndikum, VN; Ngu, JA; Niba, PTN; Nji, AM; Nna, DRA; Oben, OLA; Omgba, PAM; Selly-Ngaloumo, AA; Tatah, FM; Ticha, JT	1
Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G	1
Amaratunga, C; Callery, JJ; Chau, NH; Chotivanich, K; Chotsiri, P; Day, NPJ; Dhorda, M; Dondorp, AM; Duanguppama, J; Dung, NTP; Hien, TT; Hoglund, RM; Imwong, M; Lek, D; Long, LT; Maude, RJ; Miotto, O; Mukaka, M; Nghia, HDT; Nguon, C; Peto, TJ; Rekol, H; Ruecker, A; Sokha, M; Sovann, Y; Tarning, J; Thuong, NTH; Tripura, R; van der Pluijm, RW; Van Luong, V; von Seidlein, L; Waithira, N; White, NJ	1
Asinya, M; Jeuronlon, MK; Kamara, P; Koko, VS; Kollie, A; Ma, L; Menard, D; Nyansaiye, P; Parwon, S; Pratt, OJ; Ringwald, P; Taweh, F; Tehmeh, L; Vonhm, B; Warsame, M	1
Basco, LK; Briolant, S; Casimiro, PN; Kobawila, SC; Matondo Diassivi, B; Ndounga, M; Pembet Singana, B; Ringwald, P; Youndouka, JM	1
Baguiya, A; Barry, N; Hien, D; Kaboré, JMT; Siribié, M; Sirima, SB; Soulama, I; Tchouatieu, AM; Tiono, AB	1
Adegnika, AA; Akinosho, MA; Davi, SD; Dimessa-Mbadinga, LB; Handrich, C; Kreidenweiss, A; Kremsner, PG; Lell, B; Mombo-Ngoma, G; Ndzebe-Ndoumba, WF; Nordmann, T; Okwu, DG; Ramharter, M; Stelzl, D; Veletzky, L; Zoleko-Manego, R	1
Andrianaranjaka, VHI; Dodoson, BT; Fenomanana, J; Rakotoarisoa, MA; Ratsimbasoa, A	1
Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R	1
Adehossi, E; Arzika, II; Lamine, MM; Lobo, NF; Mahamadou, A; Mahmud, O; Maman Laminou, I; Sandrine, H; Sarr, D; Sarrasin-Hubert, V; Tidjani, IA	1
Abdelkader, O; Boulotigam, K; Djimadoum, M; Djimrassengar, H; Doderer-Lang, C; Hassoumi, M; Issa, AH; Issa, MS; Mahamat, MHT; Menard, D; Ndihiokubwayo, JB; Rasmussen, C; Saleh, IDM; Warsame, M	1
Carn, G; Harimanana, AN; Hotahiene, R; Irinantenaina, J; Ralemary, N; Randriamiarinjatovo, DNAL; Randrianarivelojosia, M; Randriarison, M; Razafinjato, C; Razanatsiorimalala, S	1
Berhane, A; Campagne, P; Criscuolo, A; Doderer-Lang, C; Fidock, DA; Legrand, E; Ma, L; Ménard, D; Mihreteab, S; Petiot, N; Platon, L; Ringwald, P; Stokes, BH; Ward, KE; Warsame, M; Zehaie Kassahun, A	1
Arama, C; Beavogui, AH; Dicko, A; Djimde, A; Djimde, M; Fofana, B; Kayentao, K; Mens, PF; Ouedraogo, JB; Sagara, I; Schallig, HD; Sirima, SB; Tshiongo, JK	1

Reviews

5 review(s) available for amodiaquine and cgp-56697

Article	Year
Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon. Drugs in R&D, 2019, Volume: 19, Issue:1 Topics: Amodiaquine; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Drug Combinations; Humans; Malaria, Falciparum; Plasmodium falciparum	2019
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data. BMC medicine, 2020, 02-25, Volume: 18, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum	2020
Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria. The Cochrane database of systematic reviews, 2021, 01-15, Volume: 1 Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Atovaquone; Cameroon; Child; Colombia; Drug Combinations; Ethiopia; Humans; Malaria, Falciparum; Mefloquine; Proguanil; Randomized Controlled Trials as Topic; Thailand; Treatment Failure	2021
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations. Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4 Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations	2021
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis. PloS one, 2022, Volume: 17, Issue:3 Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines	2022

Trials

66 trial(s) available for amodiaquine and cgp-56697

Article	Year
A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2007, Volume: 101, Issue:4 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fever; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Sulfadoxine; Treatment Outcome	2007
The effects of artemether-lumefantrine vs amodiaquine-sulfalene-pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children. Parasitology research, 2007, Volume: 100, Issue:3 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hepatomegaly; Humans; Malaria, Falciparum; Male; Pyrimethamine; Sulfalene; Time Factors; Treatment Outcome	2007
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. Lancet (London, England), 2007, Feb-10, Volume: 369, Issue:9560 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Pyrimethamine; Recurrence; Sulfadoxine; Treatment Outcome	2007
Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA, 2007, May-23, Volume: 297, Issue:20 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sesquiterpenes; Single-Blind Method; Sulfadoxine; Treatment Outcome; Uganda; Urban Population	2007
Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. The American journal of tropical medicine and hygiene, 2007, Volume: 77, Issue:2 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Pyrimethamine; Sulfalene	2007
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-01, Volume: 45, Issue:11 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine	2007
Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malaria journal, 2008, Jan-08, Volume: 7 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Feasibility Studies; Fever; Fluorenes; Ghana; Humans; Infant; Malaria; Nigeria; Patient Acceptance of Health Care; Treatment Outcome; Uganda	2008
Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malaria journal, 2008, Jun-11, Volume: 7 Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Muscle Weakness; Pyrimethamine; Single-Blind Method; Sulfadoxine; Uganda	2008
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malaria journal, 2008, Jul-11, Volume: 7 Topics: Adolescent; Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Ghana; Humans; Infant; Leukocyte Count; Malaria, Falciparum; Male; Neutrophils; Plasmodium falciparum; Polymerase Chain Reaction; Treatment Outcome	2008
A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. Malaria journal, 2008, Dec-19, Volume: 7 Topics: Amodiaquine; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Ghana; Humans; Infant; Malaria, Falciparum; Patient Acceptance of Health Care; Plasmodium falciparum; Treatment Outcome	2008
Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda. The Journal of infectious diseases, 2009, Dec-01, Volume: 200, Issue:11 Topics: Amino Acid Sequence; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sequence Alignment; Sulfadoxine; Uganda	2009
Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Journal of tropical pediatrics, 2010, Volume: 56, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Gametogenesis; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum; Polymerase Chain Reaction; Pyrimethamine; Sulfalene; Treatment Outcome	2010
Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Tropical medicine & international health : TM & IH, 2010, Volume: 15, Issue:5 Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Cote d'Ivoire; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Senegal; Statistics as Topic; Young Adult	2010
Use of area under the curve to evaluate the effects of antimalarial drugs on malaria-associated anemia after treatment. American journal of therapeutics, 2011, Volume: 18, Issue:3 Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum	2011
Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance. Malaria journal, 2010, Nov-22, Volume: 9 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Time Factors	2010
A simple dose regimen of artesunate and amodiaquine based on age or body weight range for uncomplicated falciparum malaria in children: comparison of therapeutic efficacy with standard dose regimen of artesunate and amodiaquine and artemether-lumefantrin American journal of therapeutics, 2012, Volume: 19, Issue:4 Topics: Administration, Oral; Adolescent; Age Factors; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Malaria, Falciparum; Polymerase Chain Reaction; Treatment Outcome	2012
Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:5 Topics: Amodiaquine; Anemia; Antimalarials; Area Under Curve; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Nigeria; Treatment Outcome	2011
Oral artesunate-amodiaquine and artemether-lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children. Journal of tropical pediatrics, 2012, Volume: 58, Issue:2 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Treatment Outcome	2012
Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malaria journal, 2011, Aug-12, Volume: 10 Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Senegal; Treatment Outcome; Young Adult	2011
A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS medicine, 2011, Volume: 8, Issue:11 Topics: Adult; Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male	2011
Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial. Malaria journal, 2011, Dec-13, Volume: 10 Topics: Amodiaquine; Anemia; Animals; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Community Health Workers; Disease Management; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Health Promotion; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Prevalence; Preventive Health Services; Pyrimethamine; Rural Population; Seasons; Senegal; Sulfadoxine	2011
Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Malaria journal, 2012, May-25, Volume: 11 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Secondary Prevention; Treatment Outcome	2012
Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact. The American journal of tropical medicine and hygiene, 2012, Volume: 87, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Male; Mali; Pyrimethamine; Sulfadoxine	2012
Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia. Acta medica Indonesiana, 2012, Volume: 44, Issue:3 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine; Time Factors	2012
Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine. Malaria journal, 2012, Dec-17, Volume: 11 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bradycardia; Child; Child, Preschool; Drug Combinations; Electrocardiography; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Malaria; Male; Risk Factors	2012
Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal. Malaria journal, 2012, Dec-27, Volume: 11 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Chemistry, Pharmaceutical; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Parasite Load; Senegal; Treatment Outcome	2012
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Malaria journal, 2013, Jul-17, Volume: 12 Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Young Adult	2013
Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority Malaria journal, 2013, Jul-17, Volume: 12 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Liberia; Malaria, Falciparum; Male; Treatment Outcome	2013
Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial. Trials, 2013, Sep-23, Volume: 14 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Clindamycin; Clinical Protocols; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Incidence; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine; Recurrence; Research Design; Retreatment; Time Factors; Treatment Outcome; Uganda	2013
Efficacy of artemisinin combination therapy for the treatment of uncomplicated falciparum malaria in Nigerian children. Journal of infection in developing countries, 2013, Dec-15, Volume: 7, Issue:12 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasite Load; Parasitemia; Polymerase Chain Reaction; Treatment Outcome	2013
Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Re Malaria journal, 2014, Jan-07, Volume: 13 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Central African Republic; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Prospective Studies	2014
Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Tropical medicine & international health : TM & IH, 2014, Volume: 19, Issue:4 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Therapeutic Equivalency	2014
Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Erythrocyte Count; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome	2014
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique. Malaria journal, 2014, Aug-10, Volume: 13 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Mozambique; Treatment Outcome	2014
Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children. The American journal of tropical medicine and hygiene, 2014, Volume: 91, Issue:5 Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Nigeria; Parasitemia; Prevalence; Treatment Outcome	2014
Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Malaria journal, 2014, Nov-19, Volume: 13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Cote d'Ivoire; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Middle Aged; Treatment Outcome; Young Adult	2014
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial. Reproductive health, 2015, Jan-15, Volume: 12 Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Birth Weight; Burkina Faso; Drug Combinations; Ethanolamines; Female; Fetal Development; Fluorenes; Follow-Up Studies; Ghana; Humans; Infant, Newborn; Malaria; Malawi; Mefloquine; Placentation; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Quinolines; Zambia	2015
Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children. Malaria journal, 2015, Jan-28, Volume: 14 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Cameroon; Child; Child, Preschool; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Treatment Outcome	2015
An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh. Bangladesh Medical Research Council bulletin, 2013, Volume: 39, Issue:3 Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Bangladesh; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Treatment Outcome; Young Adult	2013
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2015, Volume: 131, Issue:1 Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Double-Blind Method; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Treatment Outcome; Young Adult	2015
Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial. Malaria journal, 2015, Aug-20, Volume: 14 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Recurrence	2015
Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children. BMC infectious diseases, 2015, Oct-26, Volume: 15 Topics: Administration, Intravenous; Adolescent; Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Prospective Studies; Treatment Outcome	2015
Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study. Malaria journal, 2015, Oct-29, Volume: 14 Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Congo; Drug Combinations; Ethanolamines; Female; Fluorenes; Genotype; Hemoglobins; Humans; Malaria, Falciparum; Male; Plasmodium falciparum; Polymerase Chain Reaction; Recurrence; Suburban Population; Treatment Outcome	2015
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial. The Journal of infectious diseases, 2016, Apr-01, Volume: 213, Issue:7 Topics: Amodiaquine; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Uganda	2016
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. The New England journal of medicine, 2016, Mar-10, Volume: 374, Issue:10 Topics: Adult; Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Young Adult	2016
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014. Malaria journal, 2016, Apr-26, Volume: 15 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Malawi; Male; Plasmodium falciparum; Recurrence	2016
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Malaria journal, 2016, 09-05, Volume: 15 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Genotype; Humans; Infant; Liberia; Malaria, Falciparum; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Protozoan Proteins; Selection, Genetic	2016
In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo. Malaria journal, 2016, Sep-06, Volume: 15 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Treatment Outcome	2016
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomise The Lancet. Global health, 2017, Volume: 5, Issue:1 Topics: Amodiaquine; Anorexia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinine; Treatment Outcome; Uganda	2017
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. Lancet (London, England), 2018, 04-07, Volume: 391, Issue:10128 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Longitudinal Studies; Malaria; Male; Naphthyridines; Quinolines; Young Adult	2018
Adherence to treatment with artemether-lumefantrine or amodiaquine-artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial. Malaria journal, 2018, Jun-04, Volume: 17, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria; Male; Patient Compliance; Retrospective Studies; Sierra Leone	2018
Persistence of High In Vivo Efficacy and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine as the First- and Second-Line Treatments for Uncomplicated Plasmodium falciparum Malaria 10 Years After Their Implementation in Gabon. Acta parasitologica, 2019, Volume: 64, Issue:4 Topics: Amodiaquine; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Gabon; Humans; Infant; Malaria, Falciparum; Prospective Studies; Sentinel Surveillance; Treatment Outcome	2019
Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial. Malaria journal, 2019, Dec-16, Volume: 18, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Monitoring; Female; Gabon; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Protozoan Proteins	2019
In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso. Malaria journal, 2020, Jan-06, Volume: 19, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Inhibitory Concentration 50; Lumefantrine; Malaria, Falciparum; Male; Mass Drug Administration; Plasmodium falciparum; Treatment Failure; Treatment Outcome	2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet (London, England), 2020, 04-25, Volume: 395, Issue:10233 Topics: Adolescent; Adult; Amodiaquine; Anthraquinones; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult	2020
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal. Scientific reports, 2020, 06-01, Volume: 10, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Microfilament Proteins; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines; Senegal; Sequence Analysis, DNA; Treatment Failure	2020
Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change. The Pan African medical journal, 2020, Volume: 35 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Malaria; Male; Polymerase Chain Reaction; Treatment Failure; Treatment Outcome	2020
Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial. Malaria journal, 2020, Jun-24, Volume: 19, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Resistance; Female; Guinea; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Treatment Failure	2020
Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa. Annals of parasitology, 2020, Volume: 66, Issue:4 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Cote d'Ivoire; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Outcome	2020
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance. The American journal of tropical medicine and hygiene, 2021, 09-07, Volume: 105, Issue:4 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Congo; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines	2021
Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018. Malaria journal, 2021, Nov-03, Volume: 20, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; DNA, Protozoan; Drug Combinations; Female; Humans; Infant; Madagascar; Malaria, Falciparum; Male; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymerase Chain Reaction; Polymorphism, Genetic; Pregnancy; Prevalence; Recurrence; Reinfection	2021
Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial. BMC infectious diseases, 2022, Feb-21, Volume: 22, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Cameroon; Child; Drug Combinations; Ethanolamines; Humans; Infant; Malaria, Falciparum; Plasmodium falciparum; Treatment Outcome	2022
Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial. The Lancet. Infectious diseases, 2022, Volume: 22, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Malaria, Falciparum; Male; Plasmodium falciparum; Recurrence; Vomiting	2022
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study. PLoS neglected tropical diseases, 2022, Volume: 16, Issue:10 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Gabon; Humans; Malaria; Malaria, Falciparum; Schistosomiasis haematobia	2022
Comparative effect of artemether-lumefantrine and artesunate-amodiaquine on gametocyte clearance in children with uncomplicated Plasmodium falciparum malaria in Madagascar. Malaria journal, 2022, Nov-14, Volume: 21, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Child, Preschool; Drug Combinations; Ethanolamines; Humans; Infant; Madagascar; Malaria, Falciparum; Plasmodium falciparum	2022
Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar. Parasite (Paris, France), 2023, Volume: 30 Topics: Amodiaquine; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Humans; Madagascar; Malaria, Falciparum	2023

Other Studies

50 other study(ies) available for amodiaquine and cgp-56697

Article	Year
Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS medicine, 2006, Volume: 3, Issue:10 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost of Illness; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Ethanolamines; Fluorenes; Health Care Costs; Humans; Infant; Malaria; Practice Guidelines as Topic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome; World Health Organization	2006
Antimalarial drug combinations in vastly different settings. Lancet (London, England), 2007, Feb-10, Volume: 369, Issue:9560 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Drug Combinations; Drug Resistance, Microbial; Ethanolamines; Fluorenes; Humans; Indonesia; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Pyrimethamine; Recurrence; Sulfadoxine	2007
pfmdr1 mutations in imported African Plasmodium falciparum isolates. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008, Volume: 102, Issue:11 Topics: Africa; Alleles; Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Genes, MDR; Genotype; Humans; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Mutation; Plasmodium falciparum	2008
Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malaria journal, 2008, Sep-27, Volume: 7 Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Blood; Child, Preschool; Drug Combinations; Ethanolamines; Fluorenes; Humans; Infant; Malaria; Microscopy; Patient Compliance; Polymerase Chain Reaction; Rural Population; Treatment Outcome	2008
PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malaria journal, 2009, Sep-07, Volume: 8 Topics: Amodiaquine; Antigens, Protozoan; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Benin; Blood; Child, Preschool; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Malaria, Falciparum; Microscopy; Molecular Diagnostic Techniques; Protozoan Proteins; Pyrimethamine; Sensitivity and Specificity; Sulfadoxine; Treatment Outcome	2009
Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malaria journal, 2010, May-24, Volume: 9 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Carrier State; Child; Child, Preschool; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Germ Cells; Humans; Infant; Infant, Newborn; Kenya; Malaria, Falciparum; Male; Models, Biological; Parasitemia; Plasmodium falciparum; Prevalence; Primaquine; Pyrimethamine; Self-Sustained Sequence Replication; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome	2010
Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:6 Topics: Amodiaquine; Analysis of Variance; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Half-Life; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. The Journal of infectious diseases, 2011, Oct-01, Volume: 204, Issue:7 Topics: Alleles; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Longitudinal Studies; Malaria, Falciparum; Male; Plasmodium falciparum; Polymorphism, Genetic; Pyrimethamine; Sulfadoxine; Time Factors; Uganda	2011
Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates. Statistics in medicine, 2012, Dec-20, Volume: 31, Issue:29 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dapsone; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Meta-Analysis as Topic; Models, Statistical; Outcome Assessment, Health Care; Proguanil; Quinolines; Regression Analysis	2012
Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009. Malaria journal, 2012, Oct-08, Volume: 11 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; DNA, Protozoan; Drug Combinations; Ethanolamines; Female; Fluorenes; Genotype; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Polymerase Chain Reaction; Togo; Treatment Outcome	2012
Trouble from the tropics: challenges in managing malaria in Rhode Island. Rhode Island medical journal (2013), 2013, May-01, Volume: 96, Issue:5 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Diagnosis, Differential; Dominican Republic; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Male; Middle Aged; Plasmodium falciparum; Practice Guidelines as Topic; Quinidine; Rhode Island; Travel; Treatment Outcome	2013
Optimum population-level use of artemisinin combination therapies: a modelling study. The Lancet. Global health, 2015, Volume: 3, Issue:12 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Administration Schedule; Drug Combinations; Drug Resistance; Ethanolamines; Fluorenes; Humans; Malaria, Falciparum; Models, Biological; Plasmodium falciparum; Quinolines; Treatment Failure	2015
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease. The New England journal of medicine, 2016, Jan-07, Volume: 374, Issue:1 Topics: Adolescent; Adult; Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hemorrhagic Fever, Ebola; Humans; Infant; Liberia; Malaria; Male; Middle Aged; Regression Analysis; Risk; Young Adult	2016
Seeking treatment for uncomplicated malaria: experiences from the Kintampo districts of Ghana. Malaria journal, 2016, Feb-20, Volume: 15 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Ghana; Humans; Malaria; Male; Middle Aged; Patient Acceptance of Health Care; Plant Extracts; Qualitative Research; Young Adult	2016
Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials. Malaria journal, 2016, Feb-25, Volume: 15 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Chromatography, Thin Layer; Counterfeit Drugs; Databases, Factual; Drug Combinations; Ethanolamines; Fluorenes; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Spectrum Analysis, Raman; Tablets	2016
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso. PloS one, 2016, Volume: 11, Issue:3 Topics: Adult; Aged; Alleles; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Gene Frequency; Genotype; Host-Parasite Interactions; Humans; Malaria, Falciparum; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Multivariate Analysis; Parasitemia; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Treatment Outcome	2016
Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013. Malaria journal, 2016, 06-22, Volume: 15 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; DNA, Protozoan; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Genotyping Techniques; Humans; Infant; Malaria, Falciparum; Male; Mutation; Plasmodium falciparum; Polymerase Chain Reaction; Prospective Studies; Protozoan Proteins; Togo; Treatment Outcome	2016
Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under. Infectious diseases of poverty, 2016, Jul-06, Volume: 5, Issue:1 Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Treatment Outcome	2016
Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malaria journal, 2017, 02-02, Volume: 16, Issue:1 Topics: Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria, Falciparum; Male; Quinolines; Recurrence; Treatment Failure	2017
Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments. Infectious diseases of poverty, 2017, Feb-07, Volume: 6, Issue:1 Topics: Adolescent; Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Treatment Outcome	2017
Anaemia following Artemisinin-Based Combination Treatments of Uncomplicated Plasmodium falciparum Malaria in Children: Temporal Patterns of Haematocrit and the Use of Uncomplicated Hyperparasitaemia as a Model for Evaluating Late-Appearing Anaemia. Chemotherapy, 2017, Volume: 62, Issue:4 Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Parasitemia	2017
Study on testicular response to prolong artemisinin-based combination therapy treatments in guinea pigs. Andrologia, 2018, Volume: 50, Issue:2 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Ethanolamines; Fluorenes; Guinea Pigs; Humans; Luteinizing Hormone; Malaria; Male; Malondialdehyde; Models, Animal; Pyrimethamine; Sperm Count; Sperm Motility; Spermatogenesis; Spermatozoa; Sulfadoxine; Testis; Testosterone; Time Factors	2018
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malaria journal, 2018, Apr-03, Volume: 17, Issue:1 Topics: Adolescent; Amodiaquine; Angola; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Parasitemia; Quinolines; Treatment Failure	2018
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials. The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:3 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Plasmodium falciparum; Quinolines; Treatment Outcome	2018
Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania. Malaria journal, 2018, Oct-17, Volume: 17, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Plasmodium falciparum; Prospective Studies; Quinolines; Tanzania	2018
Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016. Malaria journal, 2019, Jan-25, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Female; Guinea; Humans; Infant; Malaria; Male; Middle Aged; Patient Compliance; Professional Competence; Young Adult	2019
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method. Scientific reports, 2019, 01-29, Volume: 9, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult	2019
Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Interactions; Heterocyclic Compounds, 3-Ring; Oxazines; Piperazines; Pyridones	2019
Reply to Banda et al., "Interpretation of Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine". Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Interactions; Heterocyclic Compounds, 3-Ring; Oxazines; Piperazines; Pyridones	2019
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017. Malaria journal, 2019, Jun-24, Volume: 18, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Ghana; Humans; Infant; Malaria, Falciparum; Male; Prospective Studies; Treatment Outcome	2019
Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria. Infectious diseases of poverty, 2019, Aug-06, Volume: 8, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Plasmodium falciparum	2019
Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria. Parasite (Paris, France), 2019, Volume: 26 Topics: Amodiaquine; Anemia; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Disease Progression; Drug Combinations; Female; Hematocrit; Humans; Infant; Malaria, Falciparum; Male; Nigeria; Parasitemia; Sex Factors; Treatment Outcome	2019
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo. PloS one, 2019, Volume: 14, Issue:9 Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Clindamycin; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Plasmodium falciparum; Quinine	2019
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Amodiaquine; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2020
[Safety and Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine in Niger]. Bulletin de la Societe de pathologie exotique (1990), 2020, Volume: 113, Issue:1 Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Niger; Treatment Outcome	2020
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine. The Journal of antimicrobial chemotherapy, 2021, 04-13, Volume: 76, Issue:5 Topics: Africa; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Drug Combinations; Ethanolamines; Fluorenes; Heterocyclic Compounds, 3-Ring; Humans; Malaria, Falciparum; Oxazines; Piperazines; Pyridones	2021
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso. BMJ open, 2021, 02-15, Volume: 11, Issue:2 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Burkina Faso; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Feasibility Studies; Female; Humans; Malaria; Malaria, Falciparum; Pregnancy	2021
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018-2019. Malaria journal, 2021, Mar-11, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Democratic Republic of the Congo; Drug Combinations; Drug Resistance; Female; Genetic Markers; Humans; Infant; Infant, Newborn; Male; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Protozoan Proteins; Treatment Failure; Young Adult	2021
Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016. Malaria journal, 2021, May-25, Volume: 20, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Female; Humans; Infant; Malaria, Falciparum; Male; Mali	2021
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea. Malaria journal, 2021, Jun-22, Volume: 20, Issue:1 Topics: Amodiaquine; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Equatorial Guinea; Female; Humans; Infant; Male; Plasmodium falciparum; Polymorphism, Genetic; Prospective Studies; Protozoan Proteins	2021
In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018. Malaria journal, 2021, Oct-02, Volume: 20, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Humans; Infant; Malaria, Falciparum; Mozambique; Parasitemia; Safety; Treatment Outcome	2021
Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018. BMC infectious diseases, 2021, Dec-15, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ghana; Humans; Infant; Malaria; Malaria, Falciparum; Treatment Failure	2021
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers. Malaria journal, 2022, Apr-27, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Chloroquine; DNA Copy Number Variations; Female; Humans; Liberia; Malaria; Malaria, Falciparum; Membrane Transport Proteins; Plasmodium falciparum; Pregnancy	2022
Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo. Malaria journal, 2022, May-02, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artesunate; Child; Congo; Drug Combinations; Fever; Humans; Malaria; Parasitemia; Prevalence	2022
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso. Malaria journal, 2022, Jun-27, Volume: 21, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Burkina Faso; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Naphthyridines	2022
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018. The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria	2023
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger. Malaria journal, 2023, May-01, Volume: 22, Issue:1 Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Malaria, Falciparum; Niger; Plasmodium falciparum; Polymorphism, Single Nucleotide; Treatment Failure	2023
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance. Malaria journal, 2023, Aug-23, Volume: 22, Issue:1 Topics: Adult; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Chad; Female; Humans; Malaria, Falciparum; Pregnancy; Prospective Studies	2023
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea. The New England journal of medicine, 2023, Sep-28, Volume: 389, Issue:13 Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Resistance; Eritrea; Humans; Malaria, Falciparum; Plasmodium falciparum; Prevalence	2023
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa. Journal of infection in developing countries, 2023, 09-30, Volume: 17, Issue:9 Topics: Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Neutropenia; Neutrophils; Parasitemia; Plasmodium falciparum; Prospective Studies	2023